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Abstract Conversion of pimeloyl-coenzyme A (CoA) to biotin
in Escherichia coli requires at least four enzymes encoded by
genes in the bio operon. One gene, bioH, which is not present in
the bioABFCD operon, is required for the synthesis of pimeloyl-
CoA but its exact role in formation of this intermediate is
unknown. To investigate this further, we have overexpressed and
purified the bioH gene products from both E. coli (BIOH EC)
and Neisseria meningitis (BIOH NM) in E. coli. When purified
BIOH was incubated with excess CoA and analysed by
electrospray mass spectrometry a species of mass corresponding
to a BIOH:CoA complex was observed. Mutation of a
conserved serine residue to alanine (BIOH EC S82A) did not
prevent CoA binding. This is the first report of the purification
of BIOH and the observation of a small molecule bound to the
protein provides clues to its role in pimeloyl-CoA
synthesis. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Pimeloyl-coenzyme A; Biotin; Biosynthesis ;
Coenzyme A; Mass spectrometry
1. Introduction
Biotin (vitamin H) is a sulfur-containing natural product
required by a number of enzymes involved in various meta-
bolic pathways where it acts as a carrier of carbon dioxide. It
is produced by bacteria, plants and fungi but not by higher
eukaryotes. In Escherichia coli the bio operon encodes genes
required for the conversion of pimeloyl-coenzyme A (CoA),
the earliest identi¢ed intermediate, into biotin [1,2]. Recent
studies have revealed the mechanisms and three-dimensional
structures of three of these enzymes; 8-amino-7-oxononanoate
synthase (AONS, the bioF gene product), 7,8-diaminonona-
noate synthase (DANS, the bioA gene product), and dethio-
biotin synthetase (DTBS, the bioD gene product) [3^7]. The
¢nal sulfur-insertion step has been the subject of intensive
research that has revealed dethiobiotin to biotin conversion
requires not only the bioB gene product (biotin synthase, BS)
but a number of enzymes and small molecules, whose exact
roles in the mechanism are still unclear [8^11].
In contrast to these later steps, the biosynthetic pathway
leading to pimeloyl-CoA, has not yet been elucidated. Based
on the results of labelling studies with 13C-labelled acetates it
was suggested that pimeloyl-CoA biosynthesis follows modi-
¢ed fatty acid and polyketide synthesis pathways [12,13]. If
this is the case, then it raises the perplexing issue that the
biotin biosynthetic pathway uses enzymes that are themselves
biotin dependent. Both groups of investigators also speculated
that a novel acyl carrier protein (ACP) was involved in the
synthesis of pimeloyl-CoA, perhaps as a carrier for 3-oxo-
glutarate. Early genetic studies of biotin biosynthesis identi-
¢ed two genes, bioH and bioC that were involved in the steps
prior to pimeloyl-CoA synthesis in E. coli, but their exact
biochemical function has remained unclear [1]. A study of
the expression of E. coli bioH gene and its e¡ect on biotin
production was carried out [14]. Somewhat surprisingly, the
authors noted that overexpression of the bioH gene led to a
decrease of total biotin productivity and it was suggested that
this was possibly due to BIOH sequestering a biotin precur-
sor. More recently, an analysis of the BIOH sequence revealed
that it shares a highly conserved motif with the thioesterase/
acyl transferase domains of fatty acid and polyketide syn-
thases (PKSs) suggesting that BIOH could possibly transfer
pimeloyl from the active cysteinyl residue of BIOC directly to
CoA [15]. It was also observed that the bioX gene from Ba-
cillus sphaericus contains a phosphopantetheine (PP) attach-
ment site which would suggest that it is an ACP required for
pimeloyl-CoA synthesis in this bacteria.
Genes and enzymes known to be involved in bacterial pi-
meloyl-CoA biosynthesis are summarised in Fig. 1. Enzymes
with pimeloyl-CoA synthetase activity have been cloned from
B. sphaericus (bioW gene product) and Pseudomonas mendoci-
na (pauA gene product), overexpressed in E. coli and puri¢ed
[16,17]. Interestingly, the BioW and pauA (80 kDa) enzymes
have no sequence homology either to each other or to BIOH
or BIOC, and show signi¢cant di¡erences in size, subunit
organisation and enzyme kinetics. It has also been shown
that the B. sphaericus bioW gene and a bioZ gene product
from Mesorhizobium sp. R7A (which has signi¢cant homology
with L-ketoacyl-ACP synthase (ACPS) III (FabH)), can each
complement E. coli bioH deletion mutants [18]. Very recently,
two separate studies of BIOI protein from Bacillus subtilis
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expressed in E. coli have shown it to contain a cytochrome
P450 cofactor [19,20] but the nature of its substrates, either
free or protein bound, are still unclear.
Somewhat surprisingly, there have been no detailed studies
on the structure and function of either the bioH or bioC gene
products. To address this issue, we present here, for the ¢rst
time, the overexpression in E. coli of the bioH genes from
both E. coli (BIOH EC) and Neisseria meningitis (BIOH
NM). Puri¢ed BIOH EC and BIOH NM were obtained in
high yield and they have been characterised by a combination
of substrate binding and mass spectrometry. This work pro-
vides a platform for the determination of the BIOH structure
and a more thorough investigation into its function in the
biotin biosynthetic pathway.
2. Materials and methods
2.1. Materials
All chemicals were purchased from Aldrich or Sigma and were of
the highest purity. Ion exchange and metal-a⁄nity columns were pur-
chased from Amersham Pharmacia Biotech and used on an FPLC.
Size exclusion chromatography was performed on a Gilson HPLC
instrument. Oligonucleotides were from Sigma Genosys. Plasmid
and chromosomal DNA preparations were carried out using commer-
cial kits (Promega, Qiagen). Polymerase chain reactions (PCR) were
carried out using Ready-to-Go beads from Amersham Pharmacia
Biotech. PCR products were cloned into pCR2.1 using the TOPO
T/A cloning kit from Invitrogen. All other manipulations were carried
out according to standard methods. The biotin auxotrophic strain
Lactobacillus plantarum (ATCC 8014) was used in the microbial biotin
assay [21].
2.2. Cloning, overexpression and puri¢cation of the E. coli bioH gene
The bioH gene was ampli¢ed by PCR from E. coli JM101 chromo-
somal DNA template using a forward primer of 5P-CGC GCG GAA
TTC ATG AAC AAC ATC TGG TGG-3P which contains EcoRI
(underlined) and BspHI (bold) restriction sites. The reverse primer
was 5P-CGC GCG CGG ATC CTA CAC CCT CTG CTT CAA-3P
which contains a BamHI site (bold). The PCR-ampli¢ed bioH gene
was digested with BspHI and BamHI, then cloned into pET-16b (No-
vagen, Madison, WI, USA) cut with NcoI and BamHI to yield
pBIOH.
HMS174(DE3) cells were transformed with pBIOH and were used
to inoculate 500 ml 2UYT and grown overnight at 37‡C. These were
then decanted into 5 l 2UYT broth containing Amp (100 Wg/ml) and
then divided into 10U500 ml batches in 1 l shake £asks and grown to
an OD600 of 1. Isopropyl-L-D-thiogalactopyranoside (IPTG) was
added to a ¢nal concentration of 1 mM to induce BIOH production
and cells were grown for a further 3 h at 37‡C. The cells were isolated
by centrifugation, washed with 50 mM Tris, pH 7.5 (bu¡er A) and
stored at 320‡C. Sodium dodecyl sulphate^polyacrylamide gel elec-
trophoresis (SDS^PAGE) gel analysis revealed a large band at 28 kDa
as expected for BIOH (predicted MW 28 505 Da)
The cell paste was resuspended in 4U wet weight of bu¡er A and
sonicated (15 min, 30 s on/o¡) on ice. The cell extract was centrifuged
(2U20 min, 10 000 rpm) and the cell-free extract was then applied to a
FPLC ¢tted with a 26/10 Q-Sepharose column (Pharmacia). BIOH
EC was eluted using a linear 0^1 M NaCl gradient (bu¡er B, 50
mM Tris, 1 M NaCl, pH 7.5) over 20 column volumes (1 l). Analysis
of the fractions by SDS^PAGE showed that BIOH EC eluted between
110 and 160 mM NaCl. Fractions containing BIOH EC were pooled
and frozen at 320‡C. The overall yield of BIOH EC was routinely
25^40 mg from 5 l of cell culture.
2.3. Size exclusion of puri¢ed BIOH EC
Puri¢ed BIOH EC was subjected to size exclusion chromatography
on a previously calibrated Sepharose 200 HR column. A sample of
protein (5 mg/ml) was loaded onto the column and eluted with the
following bu¡er 50 mM Tris, 200 mM NaCl, 7 mM L-mercapto-etha-
nol, pH 7.5. BIOH (28.5 kDa) eluted with a retention time between
chymotrypsinogen (25 kDa) and carbonic anhydrase (29 kDa), sug-
gesting that it is monomeric in solution.
2.4. Site-directed mutagenesis of BIOH EC
The megaprimer method was used to generate single mutants of
BIOH EC [22]. Mutagenic forward primers: for BIOH S53A (5P-
TTC GGG CGT GCT CGG GGA GGA TTT-3P) and BIOH S82A
(5P-TGG TTA GGC TGG GCT CTG GGC GGG CTG-3P). The
mutagenic residues are underlined. The external forward and reverse
primers were as follows: forward (5P-GTT GTG TGG AAT TGT
GAG CGG-3P) and reverse (5P-CGC CAG GGT TTT CCC AGT
CAC G-3P). Plasmid pUC18/bioH was used as a template for the
PCR reactions. The BIOH EC S53A and S82A genes were cloned
and overexpressed in an identical manner to wild-type BIOH EC.
2.5. Cloning, overexpression and characterisation of bioH from
N. meningitis
Analysis of the complete genome of N. meningitis revealed an open
reading frame (ORF) with high amino acid sequence identity to E. coli
BIOH. Oligonucleotide primers were designed to allow PCR ampli¢-
cation of this gene from the N. meningitis strain H44/76 (a B-capsular
type). These were as follows: BIOH NM forward (5P-CCA TGG GTC
CGG ATG CGG TTA AAA AAG-3P) which contains a NcoI site
(bold) and BIOH NM reverse (5P-GGA TCC TCA ACG CAG ACC
ACC TTC AAC AAA GTC-3P) which contains a BamHI site (bold).
The mass of wild-type BIOH NM is 26 978 Da, but we made a mod-
i¢cation to the coding sequence to facilitate cloning into the pET
expression vector, inserting a Gly residue at the N-terminus of
BIOH NM (underlined in BIOH NM forward) to give a protein
with a predicted mass of 27 035 Da. The PCR-ampli¢ed gene was
cloned into plasmid pCR2.1 and sequenced to con¢rm no errors
had occurred during the PCR process. The bioH NM gene was di-
gested with NcoI and BamHI and cloned in pET-16b digested with the
same enzymes to give pBIOH NM. This was used to transform
HMS174 (DE3) cells and BIOH NM was overexpressed and puri¢ed
in an identical procedure to that used on BIOH EC using ion-ex-
change and gel-¢ltration chromatography to yield V30 mg BIOH
NM from 5 l broth.
2.6. Mass spectrometry
Mass spectrometry was performed on a Micromass Platform II
quadrupole mass spectrometer equipped with an electrospray ion
source. The spectrometer cone voltage was ramped from 40 to 70 V
and the source temperature set to 140‡C. Protein samples were sepa-
rated with a Waters HPLC 2690 with a Phenomenex C5 reverse phase
column directly connected to the spectrometer. The proteins were
eluted from the column with a 5^95% acetonitrile (containing 0.01%
tri£uoroacetic acid) gradient at a £ow rate of 0.4 ml/min. The total
ion count in the range 500^2000 m/z was scanned at 0.1 s intervals.
The scans were accumulated and spectra combined and the molecular
mass was determined by the MaxEnt and Transform algorithms of the
Mass Lynx software (MicroMass).
2.7. Binding of CoA to BIOH
To test BIOH proteins as substrates for CoA binding in vitro the
following assays were performed based on the procedure used by
Flugel et al. [23]. A typical reaction mixture contained BIOH EC,
BIOH NM or BIOH S82A (10 WM) in assay bu¡er (50 mM Tris,
pH 7.5, dithiothreitol (DTT; 1 mM), MgCl2 (10 mM)) in a ¢nal
volume of 10 ml. Where required CoA (80 WM) was added, and the
reaction incubated for 2 h at 37‡C. The reaction was quenched by
immediate freezing at 320‡C. Each reaction was defrosted and diluted
two-fold by the addition of 10 ml H2O. The total sample (20 ml) was
applied to a Resource Q ion exchange column. The column was
washed with 50 mM Tris, pH 7.5 and the protein was eluted with a
linear NaCl (0^1 M) gradient over 20 CVs. The BIOH-containing
fractions were identi¢ed by SDS^PAGE, concentrated by ultracentri-
fugation and analysed by liquid chromatography-mass spectrometry
(LC-MS).
3. Results and discussion
3.1. Cloning, overexpression and puri¢cation of the E. coli and
N. meningitis bioH gene products (BIOH EC and BIOH
NM)
Primers were designed to allow PCR ampli¢cation of the E.
coli bioH gene from chromosomal DNA template and cloning
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into a suitable expression vector. During our characterisation
of BIOH EC the complete genome sequence of N. meningitis
became available and a gene encoding an ORF (249 amino
acids) was identi¢ed which had amino acid sequence homol-
ogy (26% identity, 43% homology) to BIOH EC. Ampli¢ca-
tion of the bioH NM gene from N. meningitis genomic DNA
template was achieved by PCR. Overexpression of both bioH
genes using the T7 RNA polymerase from the pET system
produced large amounts of soluble BIOH EC and NM
(SDS^PAGE, V28 kDa, see Fig. 2A,B). Both BIOH EC
and BIOH NM were readily puri¢ed in a single step using
anion exchange chromatography to yield V10 mg puri¢ed
protein/l bacterial extract. Gel permeation chromatography
showed that both BIOH proteins behaved as monomers in
solution. We also tested for possible BIOH phosphopantethei-
nylation using the 14C-radiolabelled PP precursor, L-alanine,
but BIOH was not labelled (data not shown).
3.2. Site-directed mutagenesis of BIOH EC
Sequence analysis of BIOH EC (see Fig. 4) has revealed two
motifs (Gly X Ser X Gly) which are similar to those present in
a number of thioesterase/acyl transferase domains involved in
fatty acid and polyketide biosynthetic enzymes [15]. A serine-
containing motif has been identi¢ed as the site of phospho-
pantetheinylation in the ACP domains of various fatty acid
synthases, PKSs and non-ribosomal peptide synthetases
[24,25]. Both serine residues within these motifs were con-
verted to alanine to give the BIOH EC mutants S53A and
S82A. These mutants were overexpressed using the same con-
ditions as the wild-type BIOH EC gene. The BIOH EC S53A
mutant was found to be insoluble and we were unable to
study the properties of this protein. The BIOH EC S82A mu-
tant was soluble and behaved essentially as wild type protein
during puri¢cation.
3.3. Mass spectrometry of puri¢ed BIOH EC, BIOH NM and
BIOH EC S82A
In order to determine the accurate mass of BIOH EC and
to investigate any possible post-translational modi¢cations we
analysed the puri¢ed protein by LC-MS. The transformed ion
Fig. 1. Routes of pimelate and pimeloyl-CoA synthesis in various Gram-positive and Gram-negative bacteria. Pimelate synthesis has been
shown to require the products of the bioI gene in B. subtilis and the bioX gene product in B. sphaericus. Pimeloyl-CoA synthesis requires the
bioC and bioH gene products in E. coli, and the bioZ gene in Mesorhizobium. Pimeloyl-CoA synthetase activity has been demonstrated by
BioW from B. sphaericus and B. subtilis and the PauA enzyme from P. mendocina. All bacteria studied to date appear to use the same enzymes
(AONS, DANS, DTBS, BS) to convert pimeloyl-CoA to biotin.
Table 1
LC-MS results of in vitro BIOH:CoA binding assay
Protein CoA Observed masses (Da)
BIOH EC 3 28 502.0
BIOH EC + 28 506.6; 28 849.8, 29 272.0
BIOH NM 3 27 035.0
BIOH NM + 27 032.0; 27 802.0
BIOH EC S82A 3 28 487.0
BIOH EC S82A + 28 494.0; 28 840; 29 257
The data was generated using using MaxEntz software (Micromass)
as described in Section 2. Predicted masses are as follows: BIOH
EC (28 505 Da), BIOH EC S82A (28 489 Da), BIOH NM (27 035
Da).
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series gave rise to masses of 28 502.0 þ 5.5 Da which was in
agreement with the predicted Mr of 28 505 (see Table 1). The
BIOH EC S82A mutant gave a mass of 28 487.0 þ 4.9 Da
(predicted 28 489). The recombinant N. meningitis BIOH
NM gave a mass of 27 035.0 þ 7.4 Da (predicted 27 035).
3.4. Observation of a BIOH:CoA complex
Based on a sequence analysis of BIOH EC, Lemoine et al.
[15] suggested that a possible role for the bioH gene product
could be to transfer pimeloyl from the active cysteinyl residue
of BIOC directly to CoA. To test this hypothesis we incubated
puri¢ed BIOH EC, BIOH EC (S82A) and BIOH NM each at
10 WM with an excess of CoA (80 WM) and the BIOH-con-
taining fractions were puri¢ed by anion exchange before being
analysed by LC-MS. The results of these assays are shown in
Table 1.
Appropriate controls were also carried out containing all
the assay components in single experiments, i.e. without CoA,
MgCl2 and DTT. When BIOH EC had been incubated with
CoA, MgCl2 and DTT, the transformed spectra revealed the
presence of unmodi¢ed BIOH EC at 28 506.6 þ 6.52 Da the
appearance of two masses at 28 849.8 þ 6.52 and
29 272.0 þ 9.92 Da (see Fig. 3). The addition of 765.4 Da
corresponds with the mass of a CoA molecule (Mr 767 Da)
but we are, as yet, unsure of the nature of the 343.2 Da
adduct. Each BIOH EC in vitro assay was puri¢ed using
anion exchange, then reverse-phase chromatography before
mass spectrometry analysis and this would suggest that the
CoA is relatively tightly bound. Evidence for CoA binding to
BIOH EC from our initial experiments was further comple-
mented by studies on BIOH NM and the BIOH EC S82A
mutant. When BIOH NM was incubated with CoA, species
with masses of 27 032.0 þ 9.56 and 27 802.0 þ 8.02 Da were
observed corresponding to BIOH NM with a mass of 770
Da which is within experimental error of the mass of CoA.
The same CoA incubation and isolation was carried out on
BIOH EC S82A and masses were observed at 28 494.0 þ 6.52,
28 840.0 þ 5.40 and 29 257 þ 7.07 Da. The smaller increase is
+343 and the larger species corresponds to BIOH S82A with a
mass of 763 Da, which again matches that of CoA.
We observed the BIOH:CoA complex after incubation in a
1:8 ratio but the LC-MS showed free BIOH and BIOH:CoA.
We are currently attempting to produce fully loaded BIO-
H:CoA.
Fig. 3. The transformed LC-MS data of the BIOH EC incubated with CoA in vitro as described in Section 2.
Fig. 2. SDS^PAGE (12%) gels of (A) puri¢ed BIOH EC and (B)
puri¢ed BIOH NM used for LC-MS analysis and in vitro assays.
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These results provide evidence that BIOH EC and BIOH
NM can bind CoA in vitro and that the S82A mutation
present in the conserved Gly X Ser X Gly sequence motif in
BIOH EC did not e¡ect this binding. DTT was added to the
assay mixture to ensure CoA was in its reduced state and the
fact that BIOH EC was not modi¢ed by DTNB suggests (data
not shown) that there are no free thiols on the surface of
BIOH which could be modi¢ed by the thiol of reduced CoA.
We have yet to measure the Kd for CoA (the determination
of the CoA binding constant of the various BIOH proteins
requires the use of radiolabelled CoA and equilibrium dialysis
which we did not have access to for these initial studies). The
intracellular E. coli CoA concentration is 50 WM (grown in
glucose medium), and can be increased to s 500 WM by the
addition of 25 mM pantothenate [23]. The fact that BIOH is
isolated in the CoA-free state suggests that the CoA binding
constant may be s 100 WM and it is fortunate that the BIO-
H:CoA complex prepared in vitro is stable to electrospray
ionisation. For comparison, E. coli acyl CoA synthase is pu-
ri¢ed in an unbound form and has a Km (CoA) of 50 WM in a
steady-state apo-ACP phosphopantetheinyl transferase assay.
3.5. Amino-acid sequence analysis of BIOH
3.5.1. BIOH homologs. Previous sequence analysis of the
BIOH EC had highlighted certain motifs in the primary se-
quence that suggested that the protein belonged to the thio-
esterase family of proteins [15]. This Gly X Ser X Gly se-
quence motif was found in many thioesterase, lipase and
serine protease domains [26] and is present in two regions
within BIOH EC. Until recently, the only BIOH sequence
available from the GenBank and SwissProt databases was
the E. coli protein. During the course of this work another
¢ve sequences appeared in the databases with high sequence
similarity to E. coli BIOH. These putative BIOH proteins are
present in the genomes of pathogenic bacteria such as N.
meningitis, Pseudomonas aeruginosa, Vibrio cholera and Xylel-
la fastidiosa and the aerobic bacterium Kurthia. We carried
out a sequence alignment using CLUSTAL W to identify
conserved residues (shown in Fig. 4) and it shows that 18
residues are absolutely conserved over the length of the six
sequences. It is interesting to note that Ser53 is not conserved
but the BIOH S53A mutant is insoluble and that Ser82 of
BIOH EC is one of the residues within the conserved block
of Gly Trp Ser Leu Gly. We observed the BIOH EC
S82A:CoA complex by LC-MS but a measurement of the
Kd of this mutant will reveal if it has an e¡ect on CoA bind-
ing. This mutant will also be used in future work to determine
the biochemical function of the BIOH:CoA complex.
3.5.2. Similarity with thioesterases. The highly conserved
Gly X Ser X Gly sequence motif of BIOH highlighted in Fig.
4 has recently been found to play a crucial role in various
thioesterase enzymes [15]. Although thioesterases catalyse a
number of physiologically important reactions, only ¢ve crys-
tal structures have been reported to date from bacteria and
eukaryotic organisms. These include the E. coli medium chain
acyl-CoA thioesterase II [27] and the human acyl protein thi-
oesterase I [28]. The eukaryotic thioesterases belong to the K/L
hydrolase superfamily whereas the prokaryotic thioesterases
appear to be distant homologs. A signi¢cant fact is that
although these enzymes use either a protein-bound or a free
small molecule thioester as a substrate they each have a cata-
lytic site made up a triad of Ser, His and Asp with the Ser
residue proposed to act as the nucleophile for attack on the
carbonyl of the thioester bond. The possibility that BIOH
could belong to the thioesterase family is further strengthened
by the observation that the sequence alignment reveals three
conserved residues which could act as a potential catalytic
triad at Ser82, His235 and Asp187 or Asp207 (see Fig. 4). It
may well be that BIOH acts upon a pimeloyl-ACP substrate
and current e¡orts are aimed at detecting such a protein-
bound substrate.
3.6. Biotin production assay
A previous report had found that overexpression of BIOH
Fig. 4. Sequence alignment of BIOH proteins in the SwissProt and GenBank databases, generated using CLUSTAL W. The serine residues mu-
tated in this study are marked Ser53 (#) and Ser82 (*). The accession numbers of the BIOH sequences used are BIOH EC (E. coli, K12,
AAC76437), BIOH NM (N. meningitis MC58, AAF40724), BIOH KS (Kurthia sp. 538-KA26, BioH-II, BAB39462), BIOH VC (V. cholerae,
AAF95858), BIOH PA (P. aeruginosa, AAG03891) and BIOH XF (X. fastidiosa 9a5c, AAF84165).
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in E. coli had resulted in a decrease in the production of
(total) biotin [14]. The authors suggested that the overexpres-
sion of BIOH reduces the level of some biotin precursor,
possibly synthesised through a modi¢ed fatty acid pathway.
Increased levels of BIOH may have disrupted the normal
metabolic rate, resulting in a reduction of the speci¢c inter-
mediate(s) for pimeloyl-CoA synthesis. We tested both
pBIOH EC/HMS174 (DE3) and HMS174 (DE3) cells and
found both produced the same amount of biotin (data not
shown).
3.7. Possible roles of BIOH in biotin biosynthesis
Genetic complementation experiments coupled with enzy-
matic assays have provided clues to the functions of various
proteins involved in pimeloyl-CoA synthesis in di¡erent bac-
teria outlined in Fig. 1. Deletion strains of E. coli bioH can be
complemented by genes encoding cytochrome P-450 proteins
(bioI), pimeloyl-CoA synthetase (bioW) and L-ketoacyl-ACPS
(bioZ) in the presence of exogenous pimelic acid [16,18,29].
These results, combined with our observation of a BIO-
H:CoA complex by LC-MS, lead us to propose a possible
role for BIOH as the CoA donor to a pimeloyl-ACP (or
condensing enzyme), releasing pimeloyl-CoA. We have also
overexpressed E. coli BIOC but found it to be insoluble, so
our current studies are focused on producing soluble BIOC
and determining both the extent of any post-translational
modi¢cation and its possible interaction with BIOH (Tomc-
zyk and Campopiano, unpublished results).
Since pimeloyl-CoA synthesis appears to require protein-
bound components it also explains why a simple pimeloyl-
CoA synthetase activity (i.e. an enzyme which catalyses pime-
loyl-CoA formation from pimelate, CoA and MgATP) has
not been detected in E. coli extracts. It is interesting to note
that a recent study of the function of LipA from the lipoate
biosynthetic pathway has shown that an octanoyl-ACP is the
immediate precursor to lipoate and that free octanoate is not
[30]. Puri¢ed BIOH and labelled CoA will be valuable tools to
study pimeloyl-CoA biosynthesis in vitro. The determination
of the structure of BIOH alone and in complex with CoA will
also increase our understanding of its function in the biotin
biosynthetic pathway.
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